Dr Reddy�s Laboratories Limited
May 22, 2012 at 12:51 | Source: BizTech2.com
Apr 09, 2012 at 14:46 | Source: Moneycontrol.com
Mar 30, 2012 at 11:25 | Source: Moneycontrol.com
Oct 25, 2011 at 18:12 | Source: Reuters
Mar 09, 2011 at 16:27 | Source: PTI
Interact & exchange stock tips & market info »
Related News »
NEW YORK, May 22, 2012 /PRNewswire via COMTEX/ -- Genpact Limited (NYSE:G) , a global leader in business process and technology management, today announced that it has signed an agreement with Dr. Reddy's Laboratories (NYSE:RDY) to provide ...
May 22, 2012 at 06:06 | Source: Marketwatch
NEW YORK, May 22, 2012 /PRNewswire/ -- Genpact Limited (NYSE: G), a global leader in business process and technology management, today announced that it has signed an agreement with Dr. Reddy's Laboratories (NYSE: RDY) to provide comprehensive finance and ...
May 22, 2012 at 06:13 | Source: 4-traders (press release)
Dr. Reddy's Laboratories Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Dr. Reddy's Laboratories Limited - SWOT Analysis examines the company's key business structure and operations, history and ...
May 18, 2012 at 04:30 | Source: Transworld News
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of PLAVIX ®, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP, 75 mg & 300 mg are ...
May 17, 2012 at 23:58 | Source: 4-traders (press release)
Such factors include, but are not limited to, changes in local and global ... be materially different from actual results in the future. About Dr. Reddy's Dr. Reddy's Laboratories Ltd. (NYSE:RDY) is an integrated global pharmaceutical company ...
May 21, 2012 at 04:12 | Source: Marketwatch
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin ...
May 24, 2012 at 13:42 | Source: Financial News Network Online
The S&P is trading higher by 0.5% to 1,337 and the Dow is trading 0.4% higher to 12,678. Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin.
May 16, 2012 at 14:48 | Source: Financial News Network Online
Dr. Reddy’s Laboratories (NYSE:RDY - News ... Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our ...
May 18, 2012 at 05:20 | Source: Yahoo Finance
Dr Reddy’s Laboratories may soon launch a low-cost version of blood ... It sells products such as lanzaprazole, tacrolimus, fexofinadine and fondaparinux in the US, with limited competition.
May 16, 2012 at 18:59 | Source: Business Standard
The Dow and the S&P 500 eked out a modest gain on Thursday as investors dipped back into the market after a weak stretch, but a disappointing outlook from tech bellwether Cisco Systems and caution about Europe limited gains. U.S. stock index ...
May 11, 2012 at 03:41 | Source: Reuters